Involvement of connective tissue-type mast cells in Th1 immune responses via Stat4 expression

Blood

Volumn 105, Issue 3, 2005, Pages 1016-1020

  Kataoka, Tatsuki R ^a   Komazawa, Nobuyasu ^b   Morii, Eiichi ^b   Oboki, Keisuke ^b   Nakano, Toru ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 18 RECEPTOR; STAT4 PROTEIN; STAT6 PROTEIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; GENE ACTIVATION; GENETIC TRANSFECTION; HELPER CELL; HEMATOPOIETIC STEM CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MAST CELL; MICROPHTHALMIA; MOUSE; MUCOSA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TH1 CELL; TUMOR CELL DESTRUCTION;

EID: 12844283241     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-07-2811     Document Type: Article

References (46)

1. Maurer M, Theoharides T, Granstein RD, et al. What is the physiological function of mast cells? Exp Dermatol. 2003;12:886-910.
2. Kitamura Y, Go S, Hatanaka K. Decrease of mast cells in W/W mice and their increase by bone marrow transplantation. Blood. 1978;52:447-452.
3. v mice. J Exp Med. 1985;162:1025-1043.
4. Nabel G, Galli SJ, Dvorak AM, et al. Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells. Nature. 1981;291:332-334.
5. 40/TCGFIII. Eur J Immunol. 1990;20:1413-1416.
6. Galli SJ, Dvorak AM, Marcum JA, et al. Mast cell clones: a model for the analysis of cellular maturation. J Cell Biol. 1982;95:435-444.
7. Plaut M, Pierce JH, Watson CJ, et al. Mast cell lines produce lymphokines in response to cross-linkage of FcγRI or to calcium ionophores. Nature. 1989;339:64-67.
8. Smith TJ, Ducharme LA, Weis JH. Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3. Eur J Immunol. 1994;24:822-826.
9. Williams DE, Eisenman J, Baird A, et al. Identification of a ligand for the c-kit proto-oncogene. Cell. 1990;63:167-174.
10. Tsai M, Takeishi T, Thompson H, et al. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci U S A. 1991;88:6382-6386.
11. Kaplan MH, Sun Y-L, HoeyT, et al. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 1996;382:174-177.
12. Kaplan MH, Schinder U, Smiley ST, et al. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity. 1996;4:313-319.
13. Kaplan MH, Wurster A, Grusby MJ. A signal transducer and activator of transcription (Stat) 4-independent pathway for the development of T helper type 1 cells. J Exp Med. 1998;188:1191-1196.
14. Brizzi MF, Dentelli P, Rossa A, et al. Stat5 protein recruitment and activation in c-Kit deletion mutants. J Biol Chem. 1999;274:16965-16972.
15. Ryan JJ, Huang H, McReynolds LJ, et al. Stem cell factor activates Stat5 DNA binding in IL-3-derived bone marrow mast cells. Exp Hematol. 1997;25:357-362.
16. Shelburne CP, McCoy ME, Piekorz R, et al. Stat5 expression is critical for mast cell development and survival. Blood. 2003;102:1290-1297.
17. Sherman MA, Secor VH, Lee SK, et al. STAT6-independent production of IL-4 by mast cells. Eur J Immunol. 1999;29:1235-1239.
18. Ryan JJ, DeSimone S, Klisch G, et al. IL-4 inhibits mouse mast cell FcεRI expression through a STAT6-dependent mechanism. J Immunol. 1998; 161:6915-6923.
19. Mirmonsef P, Shelburne CP, Yeatman II F, et al. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase. J Immunol. 1999;163:2530-2539.
20. Suzuki K, Nakajima H, Kagami S, et al. Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism. J Exp Med. 2002;196:27-38.
21. Hodgkin CA, Moore KJ, Nakayama A, et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell. 1993;74:395-404.
22. Akimoto T, Numata F, Tamura M, et al. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT) 6-deficient mice. J Exp Med. 1998;187:1537-1542.
23. Akagi T, Shishido T, Murata K, et al. v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation. Proc Natl Acad Sci U S A. 2000;97:7290-7295.
24. Ito A, Morii E, Kim D-K, et al. Inhibitory effect of the transcription factor encoded by the mi mutant allele in cultured mast cells of mice. Blood. 1999;93:1189-1196.
25. Suzuki K, Nakajima H, Ikeda K, et al. IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-α production in mast cells. J Exp Med. 2003;198:1717-1727.
26. Tsujimura T, Morii E, Nozaki M, et al. Involvement of transcription factor encoded by the mi locus in the expression of c-kit receptor tyrosine kinase in cultured mast cells of mice. Blood. 1996;88:1225-1233.
27. Takebayashi K, Chida K, Tsukamoto I, et al. The recessive phenotype displayed by a dominant negative microphthalmia-associated transcription factor mutant is a result of impaired nuclear localization potential. Mol Cel Biol. 1996;16:1203-1211.
28. Hoey T, Zhang S, Schmidt N, et al. Distinct requirements for the naturally occurring splice forms Stat4α and Stat4β in IL-12 responses. EMBO J. 2003;22:4237-4248.
29. Yoshimoto T, Tsutsui H, Tominaga K, et al. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci U S A. 1999;96:13962-13966.
30. Takeda K, Tsutsui H, Yoshimoto T, et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity. 1998;8:383-390.
31. Mills CD, Kincaid K, Alt JM, et al. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000;164:6166-6173.
32. Klostergaard J, Leroux ME. Hung M-C. Cellular models of macrophage tumoricidal effector mechanisms in vitro: characterization of cytolytic responses to tumor necrosis factor and nitritic oxide pathways in vitro. J Immunol. 1991;147:2802-2808.
33. Bissonnette EY, Hogaboam CM, Wallace JL, et al. Potentiation of tumor necrosis factor-α-mediated cytotoxicity of mast cells by their production of nitric oxide. J Immunol. 1991;147:3060-3065.
34. Frucht DM, Aringer M, Galon J, et al. Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J Immunol. 2000;164:4659-4664.
35. Hoshino T, Wiltrout RH, Young HA. IL-18 is a potent coinducer of IL-13 in NK and Tcells: a new potential role for IL-18 in modulating the immune response. J Immunol. 1999;162:5070-5077.
36. H1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science. 2002;295:338-342.
37. + T cells. Nat Immunol. 2002;3:549-556.
38. Hartveit F, Thoresen S, Tangen M, et al. Mast cell changes and tumour dissemination in human breast carcinoma. Invasion Metastasis. 1984;4:146-155.
39. Ueda T, Aozasa K, Tsujimoto M, et al. Prognostic significance of mast cells in soft tissue sarcoma. Cancer. 1988;62:2416-2419.
40. Tanooka H, Kitamura Y, Sado T, et al. Evidence for involvement of mast cells in tumor suppression in mice. J Natl Cancer Inst. 1982;69:1305-1309.
41. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-252.
42. Fukao T, Frucht DM, Yap G, et al Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses. J Immunol. 2001;166:4446-4455.
43. Ito A, Kataoka TR, Kim D-K, et al. Inhibitory effect on natural killer activity of microphthalmia transcription factor encoded by the mutant mi allele of mice. Blood. 2001;97:2075-2083.
44. Kurata H, Lee HJ, O'Garra A, et al. Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity. 1999;11:677-688.
45. Usui T, Nishikomori R, Kitani A, et al. GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rβ2 chain or T-bet. Immunity. 2003;18:415-428.
46. Henkel G, Brown MA. PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer. Proc Natl Acad Sci U S A. 1994;91:7737-7741.